Irodalom:
Cholangiocarcinoma
1. Khan SA, Toledano MB, Taylor-Robinson SD: Epidemiology, risk factors, and pathogenesis of
cholangiocarcinoma. HPB (Oxford) 10: 77-82, 2008.
2. Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP: Prognostic molecular markers
in cholangiocarcinoma: A systematic review. Eur J Cancer 45: 33-47, 2009.
3. Nathan H, Aloia TA, Vauthey J-N, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM: A proposed
staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008 November 6, E-pub ahead of print.
4. Wise C, Pilanthananond M, Perry BF, Alpini G, McNeal M, Glaser SS: Mechanisms of biliary carcino
genesis and growth. World J Gastroenterol 14: 2986-2989, 2008.
5. Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y-I, Maehara Y,
Tsuneyoshi M: Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic
cholangiocarcinoma: immunohistochemical and molecular analysis. Hum Pathol 2008 October 3, E-pub
ahead of print.
6. Fava, G, Alpini G, Rychlicki C, Saccomanno S, DeMorrow S, Trozzi L, Candelaresi C, Venter J, Di Sario A,
Marzioni M, Bearzi I, Glaser S, Alvaro D, Marucci L, Francis H, Svegliati-Baroni G, Benedetti A: Leptin
enhances cholangiocarcinoma cell growth. Cancer Res 68: 6752-6761, 2008.
Hepatocellularis carcinoma
7. Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327,
2008.
8. Tanaka S, Arii S: Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci 2008 November 25,
E-pub ahead of print.
9. Greten TF, Korangy F, Manns MP, Malek NP: Molecular therapy for the treatment of hepatocellular
carcinoma. Brit J Cancer 2008 November 18, E-pub ahead of print.
10. Aravalli RN, Steer CJ, Cressman ENK: Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:
2047-2063, 2008.
11. Llovet JM, Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J
Hepatol 48 Suppl 1: S20-S37, 2008.
12. Saito S, Ojima H, Ichikawa H, Hirohashi S, Kondo T: Molecular background of a-fetoprotein in liver
Gastro 2009.qxd 5/9/2009 1:42 PM Page 316
A máj 317
cancer cells as revealed by global RNA expression analysis. Cancer Sci 99: 2402-2409, 2008.
13. Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM: Experimental models of hepatocellular
carcinoma. J Hepatol 48: 858-879, 2008.
Stem Cells
14. Alison MR, Islam S, Lim S: Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and
the ugly. J Pathol 217: 282-298, 2009.
15. Zhang L, Theise N, Chua M, Reid LM: The stem cell niche of human livers: Symmetry between development
and regeneration. Hepatology 48: 1598-1607, 2008.
16. Salnikov AV, Kusumawidjaja G, Rausch V, Bruns H, Gross W, Khamidjanov A, Ryschich E, Gebhard M-M,
Moldenhauer G, Büchler MW., Schemmer P, Herr I: Cancer stem cell marker expression in hepatocellular
carcinoma and liver metastases is not sufficient as single prognostic parameter. Cancer Letters 2008
November 19, E-pub ahead of print.
